Free shipping on orders over $150
PEPTIDE LOGIX
Sign in
Wolverine Stack research vial

peptides

Wolverine Stack

Wolverine combines BPC-157 and TB-500 for research into accelerated soft-tissue, tendon, and ligament repair — the gold standard regenerative pairing.

Research-observed benefits

  • ›Tendon/ligament repair
  • ›Reduced inflammation
  • ›Faster recovery
  • ›Gut lining support

Findings reported in in-vitro / preclinical research literature. Not therapeutic claims.

Reconstitution helper

Suggested: 3 mL BAC water → 6.67 mg/mL

Open calculator →| Storage guide

CAS Number

—

Purity

99%+

Molecular Formula

—

Stock

200 units

Order type

Purchase option

Quantity

1

Total

$80

For in-vitro research only. Not for human consumption, diagnostic, or therapeutic use. Storage at -20°C recommended for lyophilized peptides.

Wolverine Stack — Full Research Breakdown

Tailored information for researchers. All content is for in-vitro / preclinical research context only — not medical advice.

Mechanism of Action

BPC-157 (gastric pentadecapeptide; vascular and tissue repair) + TB-500 (Thymosin-β4 fragment; actin binding, angiogenesis, cell migration).

How It Helps

Considered the gold-standard regenerative pairing — research targets tendon, ligament, muscle, and gut repair with faster healing curves than either peptide alone.

Half-Life

BPC-157 ~4 hours; TB-500 ~2–3 hours; functional repair effects last days.

Onset of Effects

Injury-recovery research models show measurable improvement within 1–2 weeks.

Administration

Subcutaneous near (but not directly into) the site of injury when applicable.

Storage

Lyophilized frozen; reconstituted refrigerated, 28 days.

Reconstitution Guide

20 mg combined + 3 mL BAC → ~6.7 mg/mL total.

Precise Dosing Protocols

Acute repair phase

Dose:
250 mcg BPC-157 + 250 mcg TB-500 daily
Frequency:
Daily SC
Duration:
2–4 weeks

Maintenance

Dose:
Same dose, 3× weekly
Frequency:
M/W/F SC
Duration:
Up to 8 weeks

Stacks Well With

  • ›CJC-1295/Ipamorelin (overall recovery)
  • ›Tesamorelin (lean mass)

Research-Observed Side Effects

  • •Localized fatigue ('healing tiredness')
  • •Mild injection-site reaction

Translational Cautions

  • •Active tumor models in translational research

Cycling Guidance

Acute 4-week aggressive phase → 4-week taper → 4-week observation.

Research Highlights

  • ▸Sikiric et al.: BPC-157 accelerates tendon-to-bone healing in rodent models.
  • ▸TB-500 enhances cardiomyocyte migration and angiogenesis post-injury.

Researcher FAQ